FDA’s Science Board Reviews Agency’s $500 Million Cures Act Work Plan

Drug Industry Daily
A A
In a Tuesday meeting, the FDA’s Science Board reviewed and largely supported the agency’s proposed plan for implementing the 21st Century Cures Act over the next nine years.

To View This Article:

Login

Subscribe To Drug Industry Daily